Trulieve Cannabis Corp - TCNNF STOCK NEWS

Trulieve Cannabis Corp. has successfully closed a second tranche of its private placement of 8% Senior Secured Notes, raising US$75.0 million. This follows an earlier tranche in October 2021, bringing total gross proceeds to US$425.0 million. The funds will be allocated for capital expenditures and general corporate purposes. CEO Kim Rivers highlighted the company's strong financial profile, enabling access to favorable growth capital. The Notes will be listed on the Canadian Securities Exchange post a statutory hold period.

Trulieve Cannabis Corp. has partnered with Miami Mango to launch the Mango Haze strain exclusively for South Florida medical patients. Set to debut in late February, this partnership aims to enhance Trulieve's product offerings, showcasing a commitment to quality and patient care. Trulieve continues to dominate Florida's medical cannabis market, providing a wide range of products, including flower, pre-rolls, oils, and concentrates. The company operates in 11 states, emphasizing growth through its hub strategy and a broad selection of THC and CBD products.

Trulieve Cannabis Corp. (CSE: TRUL, OTCQX: TCNNF) announced on January 21, 2022, that it filed a resale registration on Form S-1 with the SEC for Subordinate Voting Shares issued during 2021 acquisitions. A total of 1,577,600 shares were issued to stakeholders for acquisitions involving Patient Centric of Martha's Vineyard, Nature's Remedy, and others. The filing also included a post-effective amendment updating unaudited interim financials and details on Harvest Health & Recreation Inc. acquisitions. Trulieve won't sell any shares or receive proceeds from the registered sales.

Trulieve Cannabis Corp. (OTCQX: TCNNF) announced an expanded partnership with Connected Cannabis Co. to exclusively produce, process, and retail Connected-branded products across Florida. This partnership will enhance Trulieve's offering of premium cannabis strains, already available in Arizona. Products will arrive at Trulieve’s 111 Florida dispensaries later this year. Trulieve, a leading medical cannabis provider in Florida, aims to benefit patients with a wider selection of high-quality products.

Trulieve Cannabis Corp. has launched Live Diamonds by Muse™, a new cannabis concentrate made with hydrocarbon extraction, marking a first for Florida. The initial release of 500 units sold out within 24 hours, with a new batch expected in February 2022. Retailing at $45 for 0.5 grams, the launch strain, White Fire Alien, is noted for its natural flavors. Trulieve emphasizes its commitment to high-quality products, hoping to expand patient access while delivering innovative cannabis solutions.

Trulieve Cannabis Corp. (OTCQX: TCNNF) announced the opening of its 160th dispensary in the U.S., located at 1222 Arch St. in Philadelphia. This new establishment, managed by Chamounix Ventures, LLC, offers a range of medical marijuana products including whole flower, vapes, and tinctures. The dispensary is part of Trulieve's commitment to serving Pennsylvania's patient community and will operate Monday to Saturday from 9 AM to 8 PM, and Sundays from 10 AM to 6 PM. Trulieve currently has multiple dispensaries across Pennsylvania, enhancing its market presence.